Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension

• Váldodahkkit: Macarena Orejudo (Dahkki), Raul R. Rodrigues-Diez (Dahkki), Raquel Rodrigues-Diez (Dahkki), Ana Garcia-Redondo (Dahkki), Laura Santos-Sánchez (Dahkki), Javier Rández-Garbayo (Dahkki), Pablo Cannata-Ortiz (Dahkki), Adrian M. Ramos (Dahkki), Alberto Ortiz (Dahkki), Rafael Selgas (Dahkki), Sergio Mezzano (Dahkki), Carolina Lavoz (Dahkki), Marta Ruiz-Ortega (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Hypertension is now considered as an inflammatory disease, and the kidney is a key end-organ target. Experimental and clinical studies suggest that interleukin 17A (IL-17A) is a promising therapeutic target in immune and chronic inflammatory diseases, including hypertension and kidney disease. Eleva...